Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Marketing
AbbVie pumps up the case for early subcutaneous Parkinson’s care
Delaying the use of subcutaneous Parkinson’s disease treatments by one year increases annual medical costs by 59.1%, AbbVie-sponsored research found.
Nick Paul Taylor
Oct 22, 2026 6:32am
Otsuka hit with marketing breaches after event organizer blunder
Oct 22, 2026 2:23am
Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue
Brought to you by
Bain & Company
Direct-to-patient pharma programs transform drug access: survey
Oct 21, 2026 1:24pm
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Alcon acquires Neurotech and its approved Encelto for $550M
Oct 21, 2026 10:56am
